FundLens
50
Pharma & HealthcareHold

PGIM India Healthcare

PGIM India · Direct–Growth · rank #9 of 19 by Smart Score

Data updated

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
26.4%
+25.6% vs index
3 Years
—
5 Years
—
Since launch
14.3%

Year-by-year performance

last entry = YTD
2025
-1.0%
2026
+29.1%

Why this score

PGIM India Healthcare scores 50/100 — #9 of 19 Pharma & Healthcare fund (Hold). It stands out for volatility and alpha — beating 84% of peers on volatility. The main drag is its sharpe ratio (better than only 16% of peers).

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

Sharpe ratio0.59 · 16th percentile in category
Volatility13.26 · 84th percentile in category
Fund size142.08 Cr · 8th percentile in category
Alpha9.98 · 91st percentile in category
Sortino ratio0.82 · 17th percentile in category
Expense ratio0.98% · 75th percentile in category

Top holdings

top 5 = 39.4% of portfolio
1.Divi's Laboratories Ltd11.08%
2.Sun Pharmaceutical Industries Ltd10.47%
3.Torrent Pharmaceuticals Ltd8.34%
4.Ajanta Pharma Ltd5.16%
5.Dr. Lal Pathlabs Ltd4.34%

31 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.

Other Pharma & Healthcare funds